Gilead Sciences to Present at Upcoming Investor Conferences

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:

SVB Leerink Annual Global Healthcare Conference on Wednesday, February 16 at 2:20pm ET

Raymond James Annual Institutional Investors Conference on Tuesday, March 8 at 1:05pm ET

Cowen Annual Health Care Conference on Wednesday, March 9 at 10:30am ET

The live webcasts can be accessed at the company’s investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation.

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220202005999/en/

Jacquie Ross, Investors
[email protected]

Source: Gilead Sciences, Inc.

You May Also Be Interested In

• ClearOpx Joins Leading Industry Associations to Advance Operational Standards and Key Performance Indicators Across Energy and Commodities Sectors
• Eshbal Reports First-Half 2026 Revenue of US$8.8 Million, Up 30% Year-Over-Year
• Sun Summit Minerals Commences Fieldwork at the Orbit Copper-Gold Project, Toodoggone Mining District, BC